Sun Pharmaceutical Industries Ltd Share Price Today - Live Blog for March 26, 2026

Following a noteworthy 2.40% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at 1795.40. When it comes to valuation, this stock has a PE ratio of 39.3200, with the industry PE ratio at 32.0845.

Sun Pharmaceutical Industries Ltd's share price rallied by 2.40%, reaching the current market price of 1795.40. This surge is indicative of the stock's recent positive performance.

After a notable 2.40% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at 1795.40. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0670 and an ROE of 14.8407.

Sun Pharmaceutical Industries Ltd's shares experienced a 2.40% uptick, and they are currently valued at 1795.40, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0670 and an ROE of 14.8407.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 2.40% increase and currently trading at 1795.40 per share. Investors are taking notice of this upward momentum.

Sun Pharmaceutical Industries Ltd's shares saw an increase of 2.40%, reaching the current market price of 1795.40. This development underscores the stock's growing popularity.

Sun Pharmaceutical Industries Ltd observed a remarkable 2.40% surge in its share price and is presently trading at 1795.40. The increased investor interest is driving this surge.

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 2.40%, with its current market value per share resting at 1795.40. This development highlights the stock's appeal to investors.

Sun Pharmaceutical Industries Ltd witnessed a notable 2.40% surge in its share price and is presently trading at 1795.40, captivating the attention of market participants.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 2.40%, reaching the current market price of 1795.40. This ascent signifies increased investor sentiment. The stock has an ROE of 14.8407 and debt to equity ratio of 0.0670.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 2.40% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at 1795.40 per share. The stock has an ROE of 14.8407 and debt to equity ratio of 0.0670.